Medplus Health Services Subsidiary Faces Drug License Suspension in Telangana
Medplus Health Services Limited reported that its subsidiary, Optival Health Solutions Private Limited, received a suspension order concerning a Drug License for a store located in Telangana.The development details the action taken by the Assistant Director, Drugs Control Administration, Mahabubnagar, Telangana. The order suspending the Drug License for two days at the store situated in Jadcherla, Telangana, was received on 08.04.2026.
The basis for the action cited was a contravention under Rule 65 of the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945.
Medplus Health Services Limited quantified the potential impact of this incident on financial operations. The potential revenue loss associated with the suspension is reported as Rs 0.28 lacs.
MEDPLUS Stock Price Movement
Shares of Medplus Health Services Limited today slipped by 0.29% to settle at ₹855.75 in post-market trading. The equity finished on a volume of 1.12 million shares, marking a notable dip from its previous close of ₹861.45.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.